Teenagers with obesity who take weight loss drugs such as Wegovy, Ozempic, or Victoza are less at risk of suicidal thoughts and attempts than teenagers with obesity who do not take the drugs, ...

Amgen stock dipped Monday after an analyst downgraded shares, saying the $5 billion opportunity for its weight-loss drug, ...

Douglas Twenefour, head of care at Diabetes UK sets the record straight on the most common misunderstandings about sugar, ...

Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

The future of the weight loss market might not revolve around GLP-1 drugs.

A dietitian shares the science-backed weight loss supplements that support weight loss when paired with a balanced diet and active lifestyle.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...

Read which pharmaceutical companies are addressing the risk of muscle mass loss associated with popular weight loss drugs from Novo (NOVO) and Eli Lilly (LLY).

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between ...